Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-17-048291
Filing Date
2017-09-15
Accepted
2017-09-15 17:17:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 v475236_424b5.htm 424B5 244182
2 GRAPHIC logo.jpg GRAPHIC 5531
  Complete submission text file 0001144204-17-048291.txt   252905
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-219434 | Film No.: 171088613
SIC: 2834 Pharmaceutical Preparations